Clinical studies with in-111 bledta, a tumor-imaging conjugate of bleomycin with a bifunctional chelating agent

D. A. Goodwin, C. F. Meares, L. H. Deriemer, C. I. Dlamanti, R. L. Goode, J. E. Baumert, D. J. Sartoris, R. L. Lantleri, H. D. Fawcett

Research output: Contribution to journal › Article

Original languageEnglish (US)
Pages (from-to)123
Number of pages1
JournalNuclear Medicine Communications
Volume2
Issue number2
StatePublished - 1981

Fingerprint

Bleomycin
Chelating Agents
Neoplasms
Clinical Studies

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Goodwin, D. A., Meares, C. F., Deriemer, L. H., Dlamanti, C. I., Goode, R. L., Baumert, J. E., ... Fawcett, H. D. (1981). Clinical studies with in-111 bledta, a tumor-imaging conjugate of bleomycin with a bifunctional chelating agent. Nuclear Medicine Communications, 2(2), 123.

Clinical studies with in-111 bledta, a tumor-imaging conjugate of bleomycin with a bifunctional chelating agent. / Goodwin, D. A.; Meares, C. F.; Deriemer, L. H.; Dlamanti, C. I.; Goode, R. L.; Baumert, J. E.; Sartoris, D. J.; Lantleri, R. L.; Fawcett, H. D.

In: Nuclear Medicine Communications, Vol. 2, No. 2, 1981, p. 123.

Research output: Contribution to journal › Article

Goodwin, DA, Meares, CF, Deriemer, LH, Dlamanti, CI, Goode, RL, Baumert, JE, Sartoris, DJ, Lantleri, RL & Fawcett, HD 1981, 'Clinical studies with in-111 bledta, a tumor-imaging conjugate of bleomycin with a bifunctional chelating agent', Nuclear Medicine Communications, vol. 2, no. 2, pp. 123.
Goodwin DA, Meares CF, Deriemer LH, Dlamanti CI, Goode RL, Baumert JE et al. Clinical studies with in-111 bledta, a tumor-imaging conjugate of bleomycin with a bifunctional chelating agent. Nuclear Medicine Communications. 1981;2(2):123.
Goodwin, D. A. ; Meares, C. F. ; Deriemer, L. H. ; Dlamanti, C. I. ; Goode, R. L. ; Baumert, J. E. ; Sartoris, D. J. ; Lantleri, R. L. ; Fawcett, H. D. / Clinical studies with in-111 bledta, a tumor-imaging conjugate of bleomycin with a bifunctional chelating agent. In: Nuclear Medicine Communications. 1981 ; Vol. 2, No. 2. pp. 123.
@article{ce23d94349b54e2a9efd1d6ee81c19f6,
title = "Clinical studies with in-111 bledta, a tumor-imaging conjugate of bleomycin with a bifunctional chelating agent",
author = "Goodwin, {D. A.} and Meares, {C. F.} and Deriemer, {L. H.} and Dlamanti, {C. I.} and Goode, {R. L.} and Baumert, {J. E.} and Sartoris, {D. J.} and Lantleri, {R. L.} and Fawcett, {H. D.}",
year = "1981",
language = "English (US)",
volume = "2",
pages = "123",
journal = "Nuclear Medicine Communications",
issn = "0143-3636",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Clinical studies with in-111 bledta, a tumor-imaging conjugate of bleomycin with a bifunctional chelating agent

AU - Goodwin, D. A.

AU - Meares, C. F.

AU - Deriemer, L. H.

AU - Dlamanti, C. I.

AU - Goode, R. L.

AU - Baumert, J. E.

AU - Sartoris, D. J.

AU - Lantleri, R. L.

AU - Fawcett, H. D.

PY - 1981

Y1 - 1981

UR - http://www.scopus.com/inward/record.url?scp=84936913011&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84936913011&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84936913011

VL - 2

SP - 123

JO - Nuclear Medicine Communications

JF - Nuclear Medicine Communications

SN - 0143-3636

IS - 2

ER -

Access to Document